Antidepressant pharmaceutical composition containing adenosine A1 receptor agonist
A technology of receptor agonist and composition, which is applied in the field of antidepressant drug composition, can solve the problems of long onset time, unsatisfactory effect, and many side effects, and achieve fast onset time, small side effects, and definite therapeutic effect Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment approach
[0032] As mentioned above, the mechanism of action of almost all antidepressants mainly involves the transmission of monoamine neurotransmitters, relatively many side effects, clear curative effect, but not satisfactory, and some patients are ineffective for almost all antidepressants , almost all antidepressants have a relatively long onset time, and it takes at least 2 weeks to take effect. In view of this, the present inventors conducted extensive research on antidepressants.
[0033] The inventors have found that the adenosine A1 receptor agonist 2-chloro-N6-cyclopentyladenosine (CCPA) has better antidepressant activity, and the adenosine A1 receptor agonist of a certain amount and concentration is used for For the treatment of depression, the onset of action is fast, the therapeutic effect is definite and significant, and the side effects are small. The present invention has been made based on the above findings.
[0034] Therefore, the antidepressant pharmaceutical com...
Embodiment 1
[0073] Example 1: Effect of 2-chloro-N6-cyclopentyladenosine (CCPA) in antidepressant
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


